Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
07/06/2026
Indian Oil Corporation has raised the price of domestic LPG, with each cylinder of liquefied petroleum gas increasing by 29 Indian rupees.
Latest
4 m ago
The construction of a power plant in the computing power center takes 18 months, TeraRand: The prefabricated cabin power island can be delivered for electricity in 5 months.
4 m ago
CEO of Subway China: Cash flow for each store in China is positive, and plans to open over 350 new stores this year.
7 m ago
Cui Dongshu: Since 2025, promotions and downgrading in the national passenger vehicle industry have regressed to rationality.
7 m ago
Ray announces the results of the new generation of weight loss drug trial, which can alleviate various symptoms such as sleep apnea.
9 m ago
Eli Lilly (LLY.N) announced the trial results of its new generation weight-loss drug, Retatrutide, to medical experts on Saturday. The results showed that besides promoting weight loss and relieving knee joint pain, the drug also reduces the severity of sleep apnea. In a phase III clinical trial, Eli Lilly found that weekly injection of Retatrutide can reduce moderate to severe obstructive sleep apnea symptoms in obese adults by 60.6%. In the same trial, the company also found that the drug can reduce knee joint osteoarthritis pain by up to 73.1%.
See all latest